The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Expansion Is Expected For The Biosimilar Growth Hormones Market Over The Forecast Period?
The biosimilar growth hormones market has seen considerable expansion in recent years. This market is projected to expand from $0.89 billion in 2025 to $0.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.1%. The increase observed in previous periods can be linked to factors such as the elevated cost of branded growth hormone therapies, the growing incidence of growth hormone deficiency, an uptick in pediatric growth disorder diagnoses, limited accessibility to affordable treatment options, and a reliance on hospital-based administration.
The biosimilar growth hormones market is projected to experience substantial expansion over the upcoming years, reaching $1.46 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This anticipated growth during the forecast period stems from factors such as the expiration of patents for branded growth hormones, an increase in biosimilar approvals, the wider availability of self-administration treatments, increased understanding of growth disorders, and a rise in healthcare spending across developing markets. Key developments expected during this period involve a greater embrace of affordable biosimilar growth hormones, heightened demand for growth hormone therapies for both children and adults, a growing inclination towards self-administration through subcutaneous methods, the proliferation of online pharmacies and specialized clinics, and enhanced regulatory acceptance of biosimilars.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp
Which Core Factors Are Supporting The Expansion Of The Biosimilar Growth Hormones Market?
The increasing number of children affected by growth hormone deficiency is driving the expansion of the global biosimilar growth hormone market. This deficiency results from damage to the pituitary gland or hypothalamus, which can be due to an abnormal formation present before birth (congenital) or something that developed during or after birth (acquired). For instance, in September 2023, Hormones Australia by the Endocrine Society of Australia (ESA), an Australia-based national authority for the treatment of endocrine related conditions and disease, reported that growth hormone deficiency is estimated to affect 2 to 3 out of every 10,000 people. As a result, the rising incidence of growth deficiencies in children is fueling the growth of the biosimilar growth hormones industry.
How Is The Biosimilar Growth Hormones Market Distributed Across Key Segments?
The biosimilar growth hormones market covered in this report is segmented –
1) By Route Of Administration: Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics
Subsegments:
1) By Subcutaneous: Self-administration, Professional Administration
2) By Intramuscular: Pediatric Care, Adult Care
3) By Oral: Tablets, Capsules
Which Trends Are Influencing The Direction Of The Biosimilar Growth Hormones Market?
Major companies operating in the biosimilar growth hormones market are actively developing novel solutions like human growth hormone to enhance treatment efficacy and affordability for growth hormone deficiencies. Growth hormone solutions denote medical treatments or supplements designed to stimulate or replace human growth hormone (HGH) in the body, addressing growth deficiencies or anti-aging objectives. For instance, in June 2023, Pfizer Inc., a US-based pharmaceutical company, in collaboration with OPKO Health Inc., a US-based healthcare company, obtained US Food and Drug Administration (FDA) approval for NGENLA (somatrogon-ghla). This is a once-weekly injectable human growth hormone treatment developed for pediatric patients with growth hormone deficiency (GHD). This extended-release growth hormone therapy offers a new option compared to daily injections, which can improve adherence and convenience for patients and caregivers. The approval was based on clinical studies demonstrating its efficacy and safety, marking a significant advancement in growth hormone therapies.
Who Are The Companies Shaping The Biosimilar Growth Hormones Market Landscape?
Major companies operating in the biosimilar growth hormones market are Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation
Access The Complete Biosimilar Growth Hormones Market Report:
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report
Which Geographic Region Represents The Largest Biosimilar Growth Hormones Market Share?
North America was the largest region in the biosimilar growth hormone market in 2025. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Biosimilar Growth Hormones Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp
Browse Through More Reports Similar to the Global Biosimilar Growth Hormones Market 2026, By The Business Research Company
Hormonal Contraceptives Market Report 2026
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Parathyroid Hormones Market Report 2026
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
Biosimilar Hormone Market Report 2026
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model